Point72 Hong Kong Ltd - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2022$198,000
+88.6%
20,707
+277.0%
0.01%
+75.0%
Q4 2021$105,000
+303.8%
5,492
+422.5%
0.00%
+300.0%
Q3 2021$26,000
-97.6%
1,051
-97.4%
0.00%
-97.1%
Q2 2021$1,069,000
+871.8%
41,070
+927.8%
0.04%
+191.7%
Q2 2020$110,0003,996
+14700.0%
0.01%
Q3 2019$0
-100.0%
27
-95.6%
0.00%
-100.0%
Q2 2019$15,000
-21.1%
617
-69.4%
0.00%
-42.9%
Q1 2019$19,000
-44.1%
2,019
+1.2%
0.01%
-61.1%
Q1 2018$34,0001,9960.02%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders